GE HealthCare appoints Kevin A. Lobo to Board of Directors to strengthen medtech strategy.
Article excerpt
Highlighted: the sentence this signal was extracted from
GE HealthCare appoints Kevin A. Lobo to Board of Directors to strengthen medtech strategy. Chicago, USA | March 13, 2026Global medical technology leader GE HealthCare has announced the appointment of Kevin A. Lobo to its Board of Directors, effective March 13, 2026. The move is aimed at strengthening the Chicago, USA | March 13, 2026 Global medical technology leader GE HealthCare has announced the appointment of Kevin A. Lobo to its Board of Directors, effective March 13, 2026. The move is aimed at strengthening the company's strategic direction and accelerating growth across its medical technology portfolio. Kevin A. Lobo currently serves as Chair and Chief Executive Officer of Stryker Corporation, where he has led significant global expansion, innovation, and operational excellence. With extensive leadership experience in the healthcare and medical technology sectors, his appointment is expected to bring valuable insights into scaling innovation, global market strategy, and healthcare delivery transformation. At GE HealthCare, Lobo will contribute to advancing the company's focus on precision care, digital health solutions, and next-generation medical technologies, supporting its long-term vision of improving patient outcomes and expanding access to quality healthcare globally. Industry experts note that the inclusion of seasoned leaders from across the medtech...
Keep reading with a free account
The rest of this article, and every signal for GE HealthCare, is in your free account.
